Product description
Tirzepatide is a 39-amino-acid peptide based on the GIP sequence and engineered for activity at both GIP and GLP-1 receptors. Its defined substitutions and C20 fatty-diacid modification support laboratory investigation of dual-receptor activation, incretin-pathway crosstalk, and extended signaling behavior.
The specification record provides the identity, supplied format, available quantities, and storage information needed for procurement review and sample tracking. Researchers are responsible for establishing preparation, concentration, controls, and stability procedures appropriate to their validated methods.
